10/06/2015 - 23:01
CHICAGO – Adjuvant denosumab is efficacious and safe for reducing fracture risk among women taking aromatase inhibitors (AIs) as part of their treatment for early breast cancer, finds the Austrian...
Field of Interest: Oncology
Categories:
News Feed: Internal Medicine News - Oncology